Eleanor De Groot's most recent trade in Alaunos Therapeutics Inc was a trade of 350,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 30, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics Inc | Eleanor De Groot | EVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 350,000 | 350,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Eleanor De Groot | EVP, Operations | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 22 Dec 2021 | 20,132 | 237,106 (0%) | 0% | 1.3 | 25,568 | Common Stock |
| Alaunos Therapeutics Inc | Eleanor De Groot | EVP, GM Cell Therapy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 381,188 | 381,188 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Eleanor De Groot | EVP, GM Cell Therapy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 50,825 | 257,238 (0%) | 0% | 0 | Common Stock |